Table 1.
Descriptive characteristics of 822 prostate cancer patients treated with radical prostatectomy (RP) between January 2014 and June 2023.
| Characteristic | Overall n = 822 1 |
|
|---|---|---|
| Age at surgery (in years) | 66 (61, 71) | |
| PSA (in ng/mL) | 7.1 (5.2, 10.5) | |
| pTstage | pT2 | 473 (58%) |
| pT3/pT4 | 349 (42%) | |
| pNstage | pN0 | 692 (84%) |
| pN1 | 42 (5%) | |
| pNx | 88 (11%) | |
| Gleason Grade Group | 1 | 116 (14%) |
| 2 | 426 (52%) | |
| 3 | 156 (19%) | |
| 4 | 34 (4%) | |
| 5 | 90 (11%) | |
| Lymphovascular invasion | 78 (9%) | |
| Perineural invasion | 633 (77%) | |
| Positive surgical margin | no | 565 (69%) |
| yes | 236 (29%) | |
| unknown | 21 (2%) | |
| Robotic-assisted radical prostatectomy | 664 (81%) | |
| Adjuvant radiation therapy | 77 (10%) |
1 Median (interquartile range); n (%). Abbreviations: pN = pathologic lymph node stage; PSA = prostate-specific antigen; pT = pathologic tumor stage.